Pharmacogenetics & Pharmacogenomics

Recent advances in DNA repair are DNA interstrand cross-links (ICLs) are lesions caused by a variety of endogenous metabolites, ecological exposures, and cancer chemotherapeutic agents that have two reactive groups. The general feature of these diverse lesions is that two nucleotides on opposite strands are joined covalently. Mutagenicity and carcinogenicity are clearly correlated. The somatic mutation theory of cancer holds that these agents cause cancer by causing the mutation of somatic cells. A unique feature of inter-strand cross-links repair is that both strands of DNA must be incised to completely remove the lesion. Drug dosing guidelines accomplished in sequential steps to prevent creating multiple double-strand breaks. Understanding the specificity of mutagens in bacteria has led to the direct implication of certain environmental mutagens in the causation of human cancers.

  • Cancer pharmcogenetics
  • Recent advances in DNA repair
  • Pharamcogenetic approach involved in modulating cell processes
  • Mutagenecity- its implications in cancer following chemotherapy
  • Drug dosing guidelines
  • Recent advances in variant-disease pairs
  • Pharmacology of the Vascular endothelium
  • Pharmacology of drugs affecting vascular tone and blood pressure
  • Pharmacognosy
  • Methods To determine biological targeting

Related Conference of Pharmacogenetics & Pharmacogenomics

September 25-26, 2019 Hong Kong

17th World Congress on Drug Formulation & Drug Delivery

Courtyard by Marriott Hong kong
October 07-08 2019

Global Congress on Pharmacology and Therapeutics

Paris, France
October 07-08, 2019

Innovation in Drug Design Techniques and pharmacology

| Paris, France
October 10-11, 2019

15th World Congress on Medicinal Chemistry & CADD

Dubrovnik | Croatia
October 14-15, 2019

19th World Congress on Advances in Pharmaceutical Sciences

Seoul, South Korea
Oct 23-24 2019

11th Annual Biomarkers and Clinical Research Congress

| Amsterdam, Netherlands
October 25-26, 2019

14th International Conference on Biopharma and Biotherapeutics

| Copenhagen, Denmark
October 23-24, 2019 | Copenhagen, Denmark

12th Pharma Congress

September 11-12, 2019

2nd Annual Pharmaceutical Biotechnology Congress

Singapore
November 11-12, 2019

20th Annual Pharma Middle East Congress

Istanbul, Turkey
November 18-19, 2019

European Congress on Nanomedicine and Pharmaceutical Nanotechnology

Prague, Czech Republic
November 18-19, 2019

European Conference on Pharmacovigilance & Drug Safety

Prague, Czech Republic
November 18-19, 2019

27th Global Experts Meeting on Neuropharmacology

Rome, Italy
November 19-20, 2019

20th Annual Meet on Pharmaceutical Sciences

Bangkok, Thailand
December 02-03, 2019

15th Annual Congress on Pharmacology and Toxicology

Paris, France
February 12-13, 2020

14th Global Pharmacovigilance and Clinical Trials Summit

Sydney, Australia
February 12-13, 2020

2nd International Conference on Biosimilars & Pharmaceuticals

Auckland, New Zealand
March 25-26, 2020

23rd Asia Pacific Pharma Congress

Singapore
April 01-02, 2020

13th European Biosimilars Congress 2020

London, UK
April 09-10, 2020

World Pharma Expo

Bangkok, Thailand
April 27-28, 2020

5th Pharmaceutical Chemistry Conference

Prague, Czech Republic
April 27-28, 2020

7th European Biopharma Congress

Prague, Czech Republic
May 06-07, 2020

15th Annual Meet on Euro Ethnopharmacology

Prague | Czech Republic
May 18-19, 2020

30th Annual European Pharma Congress

Berlin, Germany
May 27-28, 2020

14 th World Drug Delivery Summit

| London, UK
December 06-07, 2021

22nd Pharma Middle East Congress

Dubai, UAE

Pharmacogenetics & Pharmacogenomics Conference Speakers

Recommended Sessions

Related Journals

Are you interested in